Myocardial Fas and cytokine expression in end-stage heart failure: impact of LVAD support. - Wikidata - awgldk - TriplyDB

Myocardial Fas and cytokine expression in end-stage heart failure: impact of LVAD support.

Myocardial Fas and cytokine expression in end-stage heart failure: impact of LVAD support.

http://www.wikidata.org/entity/Q37700358

about

Left ventricular remodeling and myocardial recovery on mechanical circulatory support.Clinical and Molecular Comparison of Pediatric and Adult Reverse Remodeling With Ventricular Assist Devices.

P2860

Q33645107-070B9FFA-6D7A-427B-B4EA-C1C7F8723145 Q38417459-5D25FE83-5D2B-4C61-8A6D-18C97F46C4DD

P2860

Myocardial Fas and cytokine expression in end-stage heart failure: impact of LVAD support.

http://www.wikidata.org/entity/Q37700358

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Myocardial Fas and cytokine ex ...... ilure: impact of LVAD support.

@en

Myocardial Fas and cytokine ex ...... ilure: impact of LVAD support.

@nl

type

label

Myocardial Fas and cytokine ex ...... ilure: impact of LVAD support.

@en

Myocardial Fas and cytokine ex ...... ilure: impact of LVAD support.

@nl

prefLabel

Myocardial Fas and cytokine ex ...... ilure: impact of LVAD support.

@en

Myocardial Fas and cytokine ex ...... ilure: impact of LVAD support.

@nl

P1433

Q37700358-4EA0BD33-7452-432F-AC2E-BE7F6D8BA8E8

P1476

Q37700358-E96CE07C-FF2B-4944-9756-991640F16F9D

P2093

Q37700358-2E9E4EE8-ED53-4542-94FF-0818B0EDBF73

Q37700358-474045FC-42A8-4BCE-BA76-8EFDBDD813CE

Q37700358-4C1AFFD1-E2E3-4CBC-9F7B-A374ED1D1260

Q37700358-6A0CF043-8DCC-4FA8-88EE-D11458D40580

Q37700358-98CCD727-1549-4878-BA88-12A9F172BC28

Q37700358-9EE9D3EE-A906-45E6-9781-A6A28376932D

Q37700358-A8484AC4-7E05-458E-800C-F865BA3F5700

Q37700358-AF46D442-6982-4F1B-ABE2-C92EFE76CFB7

Q37700358-C5A2AB5A-5CFA-4F8C-883D-9D92C12457AC

P2860

Q37700358-03A9930E-A1BA-486D-A59E-6F7D829D3076

Q37700358-07336071-5B4C-4EFE-ADAA-177750F97C8E

Q37700358-1B6944FE-ADD1-4962-8C52-0AF4BE9BD95D

Q37700358-34385E4D-D8DF-4F17-8E97-60A39E996337

Q37700358-3F23777B-26C6-468D-A192-098DAB1301B8

Q37700358-3FAFDAC1-2788-4CCA-816F-435F702880B8

Q37700358-422AB2BD-B30E-41A7-8505-298F8218A2FF

Q37700358-57079D4F-F5BF-48D4-BFF4-5DB3B0135B4F

Q37700358-72985F26-010F-4212-BF09-5ED7512666D2

Q37700358-7DE656FF-8E9D-46EA-BD08-B6498360EDE1

P304

Q37700358-6E7FA368-E426-4BB7-8886-71BA3BC48C85

P31

Q37700358-EE9A5E38-B897-42E2-9478-D63F16D43FE7

P356

Q37700358-28B89A13-4E48-407C-B586-CFCE24622055

P407

Q37700358-1E1F306E-8B45-4C8A-A7A4-AFA6F93E8249

P433

Q37700358-D10D922F-21F2-4423-8136-0706E2D5DDF8

P478

Q37700358-2D4DA62B-1EC1-4049-8C51-A61D62593FEE

P577

Q37700358-14684DE3-6994-4356-A868-F2B8291E67CF

P698

Q37700358-A2C7326B-B844-45B5-A00D-05A930FC5225

P921

Q37700358-AA4E1E1D-F3E5-4FFB-BFB3-47BA59908494

P932

Q37700358-901EF34E-7905-4CCC-9682-EA4D0FEC5773

P356

J.1752-8062.2008.00056.X

P1433

Clinical and Translational Science

P1476

Myocardial Fas and cytokine ex ...... ilure: impact of LVAD support.

@en

P2093

Arthur M Feldman

http://www.w3.org/2001/XMLSchema#string

Charles F McTiernan

http://www.w3.org/2001/XMLSchema#string

Dennis M McNamara

http://www.w3.org/2001/XMLSchema#string

Maninder S Bedi

http://www.w3.org/2001/XMLSchema#string

Michael P Siegenthaler

http://www.w3.org/2001/XMLSchema#string

Rene J Alvarez

http://www.w3.org/2001/XMLSchema#string

Richard Sheppard

http://www.w3.org/2001/XMLSchema#string

Robert L Kormos

http://www.w3.org/2001/XMLSchema#string

Toru Kubota

http://www.w3.org/2001/XMLSchema#string

P2860

Left ventricular assist device and drug therapy for the reversal of heart failure

The cardiac Fas (APO-1/CD95) Receptor/Fas ligand system : relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes

Long-term use of a left ventricular assist device for end-stage heart failure.

Apoptosis in the cardiovascular system.

Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline

Apoptosis and heart failure: mechanisms and therapeutic implications.

Role of cytokines in heart failure.

Apoptosis: a pivotal event or an epiphenomenon in the pathophysiology of heart failure?

Myocardial tumor necrosis factor-alpha expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support.

P304

245-248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1752-8062.2008.00056.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20443855

http://www.w3.org/2001/XMLSchema#string

P921

P932

5350672

http://www.w3.org/2001/XMLSchema#string